$7.76
+0.03 (0.39%)
Kazia Therapeutics Limited American Depositary Shares (KZIA)
Company News
Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
The leptomeningeal metastases market is projected to grow slowly due to rising cancer incidence and increasing central nervous system complications. Several emerging therapies like REYOBIQ and Paxalisib are expected to drive market development in the coming years.
S&P 500 Rises Over 1%; Citigroup Reports Upbeat Q2 Results - Benzinga
The S&P 500 index rose over 1% on Friday, with Citigroup reporting better-than-expected Q2 results. Vicinity Motor, Nisun International, and Zapp Electric Vehicles saw significant stock price increases, while Shineco and Kazia Therapeutics experienced declines.
Beat the Market the Zacks Way: Kazia Therapeutics, Uber, Medtronic in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.